APA

Tardiff B. E., Califf R. M., Tcheng J. E., Lincoff A. M., Sigmon K. N., Harrington R. A., Mahaffey K. W., Ohman E. M., Teirstein P. S., Blankenship J. C., Kitt M. M. & Topol E. J. (19990217). Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. : Journal of the American College of Cardiology.

Chicago

Tardiff B E, Califf R M, Tcheng J E, Lincoff A M, Sigmon K N, Harrington R A, Mahaffey K W, Ohman E M, Teirstein P S, Blankenship J C, Kitt M M and Topol E J. 19990217. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. : Journal of the American College of Cardiology.

Harvard

Tardiff B. E., Califf R. M., Tcheng J. E., Lincoff A. M., Sigmon K. N., Harrington R. A., Mahaffey K. W., Ohman E. M., Teirstein P. S., Blankenship J. C., Kitt M. M. and Topol E. J. (19990217). Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. : Journal of the American College of Cardiology.

MLA

Tardiff B E, Califf R M, Tcheng J E, Lincoff A M, Sigmon K N, Harrington R A, Mahaffey K W, Ohman E M, Teirstein P S, Blankenship J C, Kitt M M and Topol E J. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. : Journal of the American College of Cardiology. 19990217.